3.1 Antenatal Testing Methods & Indications for Fetal Surveillance

Clinical Purpose and Principles of Antenatal Fetal Surveillance

The overarching objective of antenatal fetal surveillance is to reduce the risk of intrauterine fetal demise (stillbirth) and prevent hypoxic-ischemic neurological injury by detecting fetal physiologic compromise at a stage when intervention or delivery can prevent permanent morbidity or death. Fetal surveillance techniques do not prevent acute, unpredictable obstetric catastrophes (such as sudden massive placental abruption or acute umbilical cord prolapse), but rather detect progressive, chronic uteroplacental insufficiency—a condition where the placenta cannot meet the respiratory, nutritional, or metabolic demands of the developing fetus.

In accordance with guidelines established by the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal-Fetal Medicine (SMFM), and the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN), testing modalities are initiated at a gestational age when the risk of fetal demise exceeds the neonatal morbidity and mortality associated with preterm delivery, and only when reliable neonatal intensive care interventions are clinically available.

---

Maternal, Fetal, and Obstetric Indications for Surveillance

Fetal surveillance is indicated whenever maternal medical conditions or pregnancy-specific complications elevate the statistical risk of stillbirth above baseline (generally when the anticipated stillbirth rate exceeds 0.8 per 1,000 births). Common indications, surveillance initiation timing, and recommended frequencies are detailed below:

---

Maternal Perception of Fetal Movement (Kick Counting)

Fetal motor activity is a direct reflection of central nervous system integrity and adequate tissue oxygenation. Normal fetal movement begins early in gestation, with maternal perception (quickening) typically occurring between 16 and 20 weeks. In the third trimester, a healthy fetus establishes distinct behavioral state cycles alternating between quiet sleep (non-rapid eye movement, lasting 20–40 minutes, rarely exceeding 75–90 minutes) and active wakefulness accompanied by gross body movements and fetal heart rate accelerations.

When hypoxemia develops, the fetus adapts by reducing oxygen expenditure. Cessation of gross body movement occurs as an early behavioral defense mechanism to divert oxygen to vital organ beds (the brain, myocardium, and adrenal glands). Consequently, maternal report of Decreased Fetal Movement (DFM) is a major clinical red flag associated with fetal growth restriction, oligohydramnios, placental abruption, fetomaternal hemorrhage, and impending intrauterine demise.

Validated Kick-Counting Protocols

• Count-to-Ten (Cardiff / Modified Moore Protocol): The pregnant individual rests in a quiet room in a left-lateral or semi-recumbent position (optimizing vena caval return and uteroplacental blood flow) and records the time required to perceive 10 distinct fetal movements (kicks, rolls, flutterings, or swishes). In healthy gestations, 10 movements are typically perceived within 30 to 60 minutes. If 10 movements are NOT felt within 2 hours, or if maternal movement perception decreases dramatically compared to baseline, the patient must be instructed to report immediately for formal clinical evaluation.
• Fixed-Time Method (Sadovsky Protocol): The patient counts movements for 1 hour following a meal; fewer than 4 distinct movements in 1 hour warrants extending the count for an additional hour or immediate presentation for clinical assessment.

Clinical Management of Decreased Fetal Movement

Any patient presenting to an inpatient or triage obstetric unit with decreased fetal movement must undergo immediate evaluation:

1. Continuous Electronic Fetal Monitoring (EFM): Initiate immediate external cardiotocography to evaluate baseline fetal heart rate, baseline variability, presence of accelerations, and deceleration patterns (performing a full Nonstress Test).
2. Ultrasound Assessment: Evaluate amniotic fluid volume (Single Deepest Vertical Pocket [SDP]) and complete a formal Biophysical Profile (BPP).
3. Screen for Fetomaternal Hemorrhage: In cases of persistent, unexplained nonreactivity or sinusoidal FHR patterns, obtain maternal blood for Kleihauer-Betke (KB) testing or flow cytometry to rule out massive fetomaternal hemorrhage.

---

Advanced Doppler Velocimetry in High-Risk Pregnancies

Doppler ultrasonography provides non-invasive hemodynamic assessment of maternal and fetal vascular beds, offering physiological insights into placental resistance, fetal cardiac performance, and tissue perfusion redistribution.

+-------------------------------------------------------------------------------------------------------------------+
|                                 DOPPLER VELOCIMETRY IN FETAL SURVEILLANCE                                          |
+-------------------------------------------------------------------------------------------------------------------+
                                                         |
                   +-------------------------------------+-------------------------------------+
                   |                                                                           |
     [ UMBILICAL ARTERY (UA) DOPPLER ]                                           [ MIDDLE CEREBRAL ARTERY (MCA) DOPPLER ]
                   |                                                                           |
   Evaluates Downstream Placental Resistance                                    Evaluates Fetal Anemia & Brain Sparing
   - Normal: Low resistance, high forward diastolic flow                        - Peak Systolic Velocity (MCA-PSV) >1.5 MoM
   - Elevated S/D ratio: >95th percentile                                         predicts moderate-to-severe fetal anemia
   - Absent End-Diastolic Velocity (AEDV)                                       - Decreased Pulsatility Index (PI <5th %ile)
   - Reversed End-Diastolic Velocity (REDV) [CRITICAL]                            demonstrates "Brain-Sparing" vasodilation

1. Umbilical Artery (UA) Doppler Velocimetry

• Physiologic Basis: Under normal conditions, the placenta is a low-resistance vascular bed. As gestation advances, tertiary stem villi proliferate and dilate, leading to continuous forward diastolic blood flow in the umbilical arteries (demonstrated by a progressively declining Systolic/Diastolic [S/D] ratio, Resistance Index [RI], and Pulsatility Index [PI]).
• Pathophysiologic Spectrum in Placental Disease: In severe placental insufficiency (such as preeclampsia or placental-mediated FGR), widespread microvascular obliteration, thrombosis, and fibromuscular sclerosis of tertiary villi elevate placental vascular afterload:
  • Elevated S/D Ratio (>95th percentile for gestational age): Early indicator of placental compromise.
  • Absent End-Diastolic Velocity (AEDV): Occurs when ≥50% to 60% of the placental villous vascular tree is obliterated. Blood flow ceases during ventricular diastole.
  • Reversed End-Diastolic Velocity (REDV): Represents extreme afterload where ≥70% of the villous bed is destroyed. High placental resistance forces blood to flow retrograde (backward toward the fetal heart) during diastole. REDV is associated with profound fetal acidemia, high perinatal mortality (>50%), and warrants urgent delivery planning.
• Delivery Thresholds for Abnormal UA Doppler (SMFM / ACOG Guidelines):
  • FGR with Normal UA Doppler: Deliver at 38 0/7 to 39 0/7 weeks.
  • FGR with Elevated S/D Ratio / Decreased Diastolic Flow: Deliver at 37 0/7 weeks.
  • FGR with Persistent Absent End-Diastolic Velocity (AEDV): Deliver at 33 0/7 to 34 0/7 weeks (following a course of antenatal corticosteroids).
  • FGR with Persistent Reversed End-Diastolic Velocity (REDV): Deliver at 30 0/7 to 32 0/7 weeks (following antenatal corticosteroids and magnesium sulfate for neuroprotection), or earlier if biophysical testing deteriorates.

2. Middle Cerebral Artery (MCA) Doppler

• MCA Peak Systolic Velocity (PSV) for Fetal Anemia: When fetal hemoglobin drops (secondary to Rh isoimmunization, Kell alloimmunization, parvovirus B19 infection, or massive fetomaternal hemorrhage), blood viscosity decreases and cardiac output increases. The resulting hyperdynamic circulation causes a dramatic increase in blood velocity through the fetal middle cerebral artery. An MCA-PSV >1.5 Multiples of the Median (MoM) for gestational age has a sensitivity >95% for detecting moderate to severe fetal anemia, replacing invasive amniocentesis (amniotic fluid delta OD450) as the standard of care.
• MCA Pulsatility Index (PI) for Brain Sparing: In the presence of chronic hypoxia, the fetal autoregulatory reflex causes cerebral arterial vasodilation to maintain perfusion to the brain. This "brain-sparing effect" is detected on Doppler by a low MCA Pulsatility Index (<5th percentile) and a reduced Cerebroplacental Ratio (CPR = MCA-PI / UA-PI <1.08).

3. Ductus Venosus (DV) Doppler

• The ductus venosus shunts oxygenated umbilical venous blood directly into the inferior vena cava toward the foramen ovale. In advanced fetal compromise, increased right atrial afterload leads to abnormal cardiac filling.
• Reversed 'a'-wave (atrial contraction wave): Indicates impending fetal myocardial failure, severe metabolic acidemia, and imminent intrauterine demise.